A long-term health study has found that seniors with a higher body mass index were less likely to make use of hospice care. Additionally, obese seniors spent significantly fewer days in hospice care than their nonobese counterparts.
A long-term health study has found that seniors with a higher body mass index (BMI) were less likely to make use of hospice care. Additionally, obese seniors spent significantly fewer days in hospice care than their nonobese counterparts.
This Health and Retirement Study (HRS) evaluated the association between BMI, hospice use, and Medicare expenditure among 5677 community-dwelling fee-for-service Medicare enrollees who died between 1998 and 2012. The primary outcomes evaluated by the researchers were:
According to senior author Jennifer Griggs, MD, MPH, hospice teams might require more staff to take care of people who are obese, “but Medicare hospice reimbursement is capped no matter what a person’s BMI.” Griggs also believes that obesity could potentially mask the typical signs and changes that physicians might use to determine the appropriate time to pass a patient on to hospice care. Although signs of cachexia might be visible even in an obese individual, the more gradual changes could be missed.
The authors reported the following for the decedent population in their study:
The lowest BMI group was used as the comparator for the 30 kg/m2 and ≥40 kg/m2 BMI groups.
“Obesity is a complex disease, and this study has shown another side of its effect on patients and the healthcare system. Patients with obesity are less likely to receive high-quality end-of-life care,” said John Harris, MD, MSc, who led the study during a fellowship at the University of Michigan. He is currently an assistant professor at the University of Pittsburgh School of Medicine.
Reference
Harris JA, Byhoff E, Perumalswami CR, Langa KM, Wright AA, Griggs JJ. The relationship of obesity to hospice use and expenditures: a cohort study [published online February 7, 2017]. Ann Intern Med. 2017. doi: 10.7326/M16-0749.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies
November 21st 2023A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.
Read More
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More